Neurotechnology Research, Development, and Enhancement (STTR [R41/R42])
National Institutes of Health · Opportunity PA-07-390
Multiple Receipt Dates - See Link to Full Announcement for details.
Who can apply
- Small businesses
- Others
Foreign institutions are not eligible to apply.
About this opportunity
Purpose. Advances in the brain and behavioral sciences are being made rapidly, vastly improving our understanding of healthy brain function and offering promise to the millions suffering from brain and behavioral disorders. This Funding Opportunity Announcement (FOA) solicits Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to enable neuroscience and behavioral research through the development of novel, or the significant enhancement or improvement of currently existing, tools and approaches to be used in brain and behavioral research. Such tools and approaches could include those used in basic or clinical research, or for clinical treatment and care (e.g., assessment, diagnosis, and treatment of brain disorders). Research solicited under this funding opportunity announcement is not limited to any particular type of technology, level of analysis, or approach. Multidisciplinary teams of researchers are especially encouraged to apply. Technologies appropriate for study, development and enhancement under this FOA include hardware, software, and wetware (and combinations thereof).
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | National Institutes of Health | August 18, 2026 23d left | — | Nonprofits |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2026 43d left | $499k | Nonprofits |
| Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2026 43d left | — | Nonprofits |
| Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) | National Institutes of Health | September 7, 2026 43d left | — | Nonprofits |